Literature DB >> 35717559

Computational investigation of the dynamic control of cAMP signaling by PDE4 isoform types.

Dean Paes1, Sammy Hermans2, Daniel van den Hove3, Tim Vanmierlo1, Jos Prickaerts2, Aurélie Carlier4.   

Abstract

Cyclic adenosine monophosphate (cAMP) is a generic signaling molecule that, through precise control of its signaling dynamics, exerts distinct cellular effects. Consequently, aberrant cAMP signaling can have detrimental effects. Phosphodiesterase 4 (PDE4) enzymes profoundly control cAMP signaling and comprise different isoform types wherein enzymatic activity is modulated by differential feedback mechanisms. Because these feedback dynamics are non-linear and occur coincidentally, their effects are difficult to examine experimentally but can be well simulated computationally. Through understanding the role of PDE4 isoform types in regulating cAMP signaling, PDE4-targeted therapeutic strategies can be better specified. Here, we established a computational model to study how feedback mechanisms on different PDE4 isoform types lead to dynamic, isoform-specific control of cAMP signaling. Ordinary differential equations describing cAMP dynamics were implemented in the VirtualCell environment. Simulations indicated that long PDE4 isoforms exert the most profound control on oscillatory cAMP signaling, as opposed to the PDE4-mediated control of single cAMP input pulses. Moreover, elevating cAMP levels or decreasing PDE4 levels revealed different effects on downstream signaling. Together these results underline that cAMP signaling is distinctly regulated by different PDE4 isoform types and that this isoform specificity should be considered in both computational and experimental follow-up studies to better define PDE4 enzymes as therapeutic targets in diseases in which cAMP signaling is aberrant.
Copyright © 2022 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35717559      PMCID: PMC9382341          DOI: 10.1016/j.bpj.2022.06.019

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   3.699


  95 in total

1.  Differential effects of cAMP in neurons and astrocytes. Role of B-raf.

Authors:  L L Dugan; J S Kim; Y Zhang; R D Bart; Y Sun; D M Holtzman; D H Gutmann
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Cyclic nucleotide research -- still expanding after half a century.

Authors:  Joseph A Beavo; Laurence L Brunton
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

3.  Signaling in small subcellular volumes. I. Stochastic and diffusion effects on individual pathways.

Authors:  Upinder S Bhalla
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

4.  The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP.

Authors:  J V Swinnen; D R Joseph; M Conti
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 5.  Phosphodiesterase Type 4 Inhibition in CNS Diseases.

Authors:  Arjan Blokland; Pim Heckman; Tim Vanmierlo; Rudy Schreiber; Dean Paes; Jos Prickaerts
Journal:  Trends Pharmacol Sci       Date:  2019-11-05       Impact factor: 14.819

6.  Discovery of Allostery in PKA Signaling.

Authors:  Ping Zhang; Alexandr P Kornev; Jian Wu; Susan S Taylor
Journal:  Biophys Rev       Date:  2015-06-01

7.  The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579.

Authors:  R Hoffmann; G S Baillie; S J MacKenzie; S J Yarwood; M D Houslay
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

8.  Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling.

Authors:  Wenkuan Xin; Tuan M Tran; Wito Richter; Richard B Clark; Thomas C Rich
Journal:  J Gen Physiol       Date:  2008-03-17       Impact factor: 4.086

9.  Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes.

Authors:  Ana Herrero; Adán Pinto; Paula Colón-Bolea; Berta Casar; Mary Jones; Lorena Agudo-Ibáñez; Rebeca Vidal; Stephan P Tenbaum; Paolo Nuciforo; Elsa M Valdizán; Zoltan Horvath; Laszlo Orfi; Antonio Pineda-Lucena; Emilie Bony; Gyorgy Keri; Germán Rivas; Angel Pazos; Rafael Gozalbes; Héctor G Palmer; Adam Hurlstone; Piero Crespo
Journal:  Cancer Cell       Date:  2015-08-10       Impact factor: 31.743

10.  Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes.

Authors:  Berta Casar; Adán Pinto; Piero Crespo
Journal:  Mol Cell       Date:  2008-09-05       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.